ONLY ORPHANS COTE LLC
Area: Multi National Companies
Booth No: L724
Website: https://www.only-orphans-cote.com/
Exhibitor Profile
Only Orphans Cote is a regulatory affairs consulting firm leveraging its expertise and commitment to delivering drugs for rare diseases. Under the guidance of Dr. Tim Cote, former Director of the Office of Orphan Products Development, we crystallize our clients’ drug development work into documents, securing FDA and EMA Orphan Drug Designations as well as all other actions that advance to marketing authorization. In doing so, we enhance investment and asset valuation in the orphan drug market.
Brands
Only Orphans Cote
Video
Exhibit Products
-
Breakthrough Therapy Designation
-
Fast Track Designation
-
IND Filing
-
IND Filing
-
FDA Meetings: INTERACT/Pre-IND Meeting, Type A, B, C and D Meetings
-
FDA Orphan Drug Designation
-
FDA Rare Pediatric Disease Designation
Exhibitor Press Release
- Global experts discuss regulatory innovations – accelerators for the approval of orphan drugs 2024-05-30
Exhibitors you may be interested in
Highest Rated